AVIRAGEN THERAPEUTICS INC Chart calendar Aviragen Therapeutics Inc
1112f9a24c2c0317dfaf0f1.1iUJJb_x1K32fXHWN8dfKMlEa0E-ChVTYSItkPj00-w.vk1cYI2ipsy8Mziyc5JuRP4zDDhIckoLCHJm0ciGhL-XZ19NyqGe6J0kSQ~58b47acbc14e6790427e16a3a3e15a67
Upcoming events on Aviragen Therapeutics Inc
Past events on Aviragen Therapeutics Inc
| 11/06/2024 16:30 | Annual General Meeting |
| 13/05/2024 21:30 | Q1 2024 Earnings Call |
| 13/05/2024 21:01 | Q1 2024 Earnings Release |
| 03/04/2024 20:10 | World Vaccine Congress |
| 14/03/2024 20:30 | Q4 2023 Earnings Call |
| 14/03/2024 20:01 | Q4 2023 Earnings Release |
| 02/11/2023 20:30 | Q3 2023 Earnings Call |
| 02/11/2023 20:01 | Q3 2023 Earnings Release |
| 19/10/2023 10:00 | World Vaccine Congress - Protection against infection from an oral tablet norovirus candidate in hum |
| 18/10/2023 13:30 | World Vaccine Congress - Transmission blocking strategies via oral tablet vaccination and mucosal im |
| 28/09/2023 19:25 | Cantor Global Healthcare Conference - Fireside Chat |
| 06/09/2023 22:00 | Monovalent Norovirus Vaccine Phase 2 Study Results Call |
| 03/08/2023 21:30 | Q2 2023 Earnings Call |
| 03/08/2023 21:01 | Q2 2023 Earnings Release |
| 26/06/2023 18:00 | Annual General Meeting |
| 04/05/2023 21:30 | Q1 2023 Earnings Call |
| 04/05/2023 21:01 | Q1 2023 Earnings Release |
| 06/04/2023 17:15 | World Vaccine Congress |
| 05/04/2023 21:40 | World Vaccine Congress |
| 28/03/2023 18:00 | Investor Meeting - Key Opinion Leader |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,86 6,50 51.72% | 4,05 8,05 -49.74% | 0,89 1,02 -12.39% | 0,11 0,79 -86.5% | 7,38 5,21 41.6% | 25,0 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -15,8 -15,6 -1.19% | -30,2 -22,6 -33.5% | -72,8 -75,2 3.22% | -115 -106 -8.4% | -83,3 -88,3 5.58% | -98,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,2 -17,9 -1.42% | -32,0 -24,2 -32.16% | -70,4 -76,3 7.78% | -108 -106 -1.4% | -82,2 -85,6 4% | -98,4 |
|
Net income Million USD | Released Forecast Spread | -18,6 -18,2 -2.45% | -32,2 -24,4 -32.05% | -70,5 -76,5 7.9% | -108 -106 -1.43% | -82,5 -85,7 3.77% | -98,4 |
|
EPS USD | Released Forecast Spread | -0,86 -0,66 -30.3% | -0,36 -0,28 -30.91% | -0,58 -0,66 12.45% | -0,84 -0,84 -0.6% | -0,57 -0,59 3.93% | -0,55 |
| Announcement Date | 19/03/20 | 25/02/21 | 24/02/22 | 15/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,09 0,13 -32% | 0,00 0,10 - | 0,00 0,05 - | 0,02 0,68 -96.74% | 0,68 0,80 -15.63% | 1,36 0,08 1529.67% | 2,10 0,10 2001% | 3,25 1,10 195% | 2,18 0,80 172.63% | 22,0 | 1,43 | -0,60 | 0,20 | 0,20 |
|
EBIT Million USD | Released Forecast Spread | -24,8 -22,3 -10.95% | -29,2 -26,3 -11.17% | -29,4 -31,3 5.86% | -31,1 -30,1 -3.35% | -25,6 -25,8 0.75% | -23,1 -25,6 9.93% | -17,8 -24,9 28.48% | -16,9 -20,6 18.06% | -24,1 -21,3 -12.85% | -3,19 | -22,5 | -27,1 | -23,8 | -24,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,1 -20,4 -23.24% | -29,4 -26,6 -10.75% | -29,3 -31,5 6.94% | -23,9 -30,3 21.23% | -25,1 -25,3 0.87% | -22,5 -25,2 10.45% | -17,4 -24,5 29.09% | -17,2 -20,2 14.81% | -24,4 -21,4 -13.74% | -3,12 | -22,4 | -26,7 | -23,7 | -24,4 |
|
Net income Million USD | Released Forecast Spread | -25,1 -20,4 -23.31% | -29,4 -26,6 -10.8% | -29,3 -31,5 6.96% | -23,9 -30,4 21.26% | -25,1 -25,4 0.91% | -22,6 -25,2 10.38% | -17,4 -24,5 28.94% | -17,4 -20,2 14.12% | -24,4 -21,6 -12.89% | -3,12 | -22,4 | -26,7 | -23,7 | -24,4 |
|
EPS USD | Released Forecast Spread | -0,20 -0,16 -23.08% | -0,23 -0,21 -12.2% | -0,23 -0,24 5.15% | -0,18 -0,23 20.88% | -0,19 -0,19 2.23% | -0,16 -0,18 11.11% | -0,11 -0,18 38.89% | -0,12 -0,13 10% | -0,14 -0,14 0% | -0,03 | -0,12 | -0,14 | -0,12 | -0,12 |
| Announcement Date | 09/05/22 | 08/08/22 | 08/11/22 | 15/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 14/03/24 | 13/05/24 | - | - | - | - | - |
More events
Past sector events for Aviragen Therapeutics Inc
| 05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
